Case Study: Allergic Rhinitis

Background: HRHR has participated in numerous research studies designed to evaluate investigational medications for allergic rhinitis. The studies required rapid enrollment of a large number of patients with proven environmental allergies. Enrollment was competitive with short windows of opportunity to enroll adequate numbers of patients.

Study Execution: Rapid start up inclusive of central IRB submission, patient screening and aggressive recruiting strategies were the key to successful study enrollments and early completion of these trials.

Responsibilities included: Aggressive recruitment objectives; close management and communication of results with study sponsor during the trial; acquisition of valid, evaluable and generalizable data.

Study Results: Knowing that the clients expected rapid enrollment, aggressive strategies were put in place to begin immediate enrollment. As a result HRHR far exceeded the contract enrollment goal in all studies. A significant volume of evaluable data was obtained and patient satisfaction, based on a standard study exit survey, was high. HRHR's recruiting strategy exemplified HRHR's commitment and confidence in meeting sponsor's goals and objectives. HRHR far exceeded the sponsor's expectations and was a major contributor to the drug development timeline.

Key to Success:

• Experienced clinical research team
• Efficient IRB process utilizing a centralized IRB.
• Aggressive recruitment strategy in advance of study start up for rapid enrollment at study initiation